J. Bates

Ribosomal S6 kinase and AKT phosphorylation as pharmacodynamic biomarkers in patients with myelodysplastic syndrome treated with RAD001.

J. Maciejewski, Y. Saunthararajah, A. Advani, 2014, Clinical Lymphoma, Myeloma & Leukemia.

Imaging of activated T cells as an early predictor of immune response to anti-PD-1 therapy.

G. Ren, H. VanBrocklin, J. Bates, 2019, Cancer research.

Absolute lymphocyte count at day 28 independently predicts event‐free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia

Ash A. Alizadeh, M. Liedtke, A. Advani, 2012, American journal of hematology.

A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.

J. Maciejewski, M. Egorin, Y. Saunthararajah, 2010, Leukemia research.

A new variant of hereditary hemolytic anemia with stomatocytosis and erythrocyte cation abnormality.

J. Bates, P. L. la Celle, M. Lichtman, 1971, Blood.

Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia

Y. Saunthararajah, A. Advani, L. Rybicki, 2012, European journal of haematology.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

M. Kalaycio, J. Bates, B. Pohlman, 2004 .

Absolute Lymphocyte Count At Day 28 Independently Predicts Event-Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia

Ash A. Alizadeh, M. Liedtke, A. Advani, 2011 .